Delphi Management’s Quest Diagnostics DGX Stock Holding History

Delphi Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,349	Closed	-$1.23M	–	104
2021 Q2	$1.23M	Buy	9,349 +402	+4%	+$52.6K	1.18%	34
2021 Q1	$1.15M	Buy	+8,947	New	+$1.1M	1.22%	42
2017 Q1	–	Sell	-21,059	Closed	-$1.94M	–	89
2016 Q4	$1.94M	Sell	21,059 -7,210	-26%	-$621K	1.13%	52
2016 Q3	$2.39M	Sell	28,269 -1,731	-6%	-$145K	1.49%	14
2016 Q2	$2.44M	Sell	30,000 -1,347	-4%	-$103K	1.57%	12
2016 Q1	$2.24M	Sell	31,347 -3,906	-11%	-$262K	1.35%	29
2015 Q4	$2.51M	Sell	35,253 -75,753	-68%	-$5.09M	1.62%	9
2015 Q3	$6.82M	Buy	+111,006	New	+$7.76M	1.07%	61
2014 Q3	–	Sell	-220	Closed	-$13K	–	119
2014 Q2	$13K	Buy	+220	New	+$12.9K	﹤0.01%	108

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Delphi Management's DGX Position: Q3 2021 in Review

Delphi Management sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 9,349 shares — an estimated $1.23M sold.

Delphi Management first reported a position in DGX in Q2 2014 and held it in 9 quarters. The position peaked at $6.82M in Q3 2015. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

Delphi Management reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
Delphi Management sold 9,349 Quest Diagnostics shares in Q3 2021, an estimated $1.23M.
Delphi Management first reported a position in Quest Diagnostics in Q2 2014 and held it in 9 quarters.
Delphi Management's Quest Diagnostics position peaked at $6.82M in Q3 2015.
837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Delphi Management's 13F filing for Q3 2021, filed 15 Nov 2021.